DocSym
β
Searchsearch
Search
(P55.9) Haemolytic disease of fetus and newborn, unspecified
More details coming soon
747 925 in individuals diagnosis haemolytic disease of fetus and newborn, unspecified confirmed
1 731 deaths with diagnosis haemolytic disease of fetus and newborn, unspecified
Diagnosis haemolytic disease of fetus and newborn, unspecified is diagnosed Women are 3.07% more likely than Men
362 484
Men receive the diagnosis haemolytic disease of fetus and newborn, unspecified
660 (0.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
385 441
Women receive the diagnosis haemolytic disease of fetus and newborn, unspecified
1 071 (0.3 %)Died from this diagnosis.
Risk Group for the Disease haemolytic disease of fetus and newborn, unspecified - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 0-95+
In Women diagnosis is most often set at age 0-1
Disease Features haemolytic disease of fetus and newborn, unspecified
Absence or low individual and public risk
Haemolytic disease of fetus and newborn, unspecified - what does this mean
Haemolytic disease of the fetus and newborn (hdfn) is an immune-mediated condition that occurs when the mother's blood type is incompatible with the baby's, resulting in the mother's antibodies attacking the baby's red blood cells. this can cause anaemia, jaundice, and other serious complications in the baby.
What happens during the disease - haemolytic disease of fetus and newborn, unspecified
Haemolytic disease of the fetus and newborn is a condition caused by an incompatibility between the mother and the fetus in regards to their blood type. in this condition, the mother's blood produces antibodies that attack the fetus' red blood cells, leading to haemolysis (breakdown of red blood cells) and anemia in the fetus. this can lead to jaundice, an enlarged spleen, and other complications in the newborn.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC)
- Blood Grouping and Typing
- Direct Coombs Test
- Indirect Coombs Test
- Fetal Ultrasound
- Fetal Blood Sampling
- Amniocentesis
- Cordocentesis
- Genetic Testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk of haemolytic disease of the fetus and newborn and to improve the health of the newborn.
- Administer Rh immunoglobulin to Rh-negative mothers during pregnancy and after delivery.
- Administer phototherapy to reduce the level of bilirubin in the newborn.
- Perform exchange transfusion to reduce the level of bilirubin in the newborn.
- Monitor the mother and baby for signs of anemia.
- Administer antibiotics to treat any infections.
- Monitor the newborn for any signs of jaundice.
- Provide nutritional support to the newborn.
- Provide psychological support to the family.
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Haemolytic disease of fetus and newborn, unspecified - Prevention
The best way to prevent haemolytic disease of fetus and newborn, unspecified, is to ensure that the mother and father are both rh negative, as this will reduce the risk of the mother developing antibodies that could attack the baby's red blood cells. additionally, rh immunoglobulin should be administered to the mother during pregnancy and after delivery to help prevent the development of antibodies.